Deferoxamine mesylate
- Product NDC
- 60505-6238
- 11-digit product format
- 605056238
- Labeler code
- 60505
- Product ID
- 60505-6238_623ee6cc-3fc4-5f3b-3c68-741f52ccd71f
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Deferoxamine mesylate
- Dosage form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Route
- INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS
- Labeler
- Apotex Corp.
- Application
- ANDA207384
- Marketing category
- ANDA
- Marketing start
- 2022-03-28
- Marketing end
- 0000-00-00
- Substance
- DEFEROXAMINE MESYLATE
- Active strength
- 500 mg/1
- Pharmacologic classes
- Iron Chelating Activity [MoA], Iron Chelator [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 60505-6238-6 | 60505623806 | 4 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 CARTON (60505-6238-6) | 2022-03-28 | 0000-00-00 | No | No | Current |